I Lost Almost $1,000 on Novo Nordisk Options. The Stock Is a Hold For Now.
I bought Novo Nordisk (NYSE: NVO) call options betting on a V-shape recovery after earnings. They’re now worth almost nothing. In this post I walk through what happened, why I still hold the stock, and why my view is a hold for now — not a buy, not a sell.